Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma

BACKGROUND: Although, micropeptides encoded by non-coding RNA have been shown to have an important role in a variety of tumors processes, there have been no reports on micropeptide in renal cell carcinoma (RCC). Based on the micropeptide MIAC (micropeptide inhibiting actin cytoskeleton) discovered a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengwei, Liu, Guangxiang, Jin, Xinrong, Guo, Hongqian, Setrerrahmane, Sarra, Xu, Xindi, Li, Tiantian, Lin, Yunfei, Xu, Hanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484220/
https://www.ncbi.nlm.nih.gov/pubmed/36117171
http://dx.doi.org/10.1186/s12943-022-01654-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484220/
https://www.ncbi.nlm.nih.gov/pubmed/36117171
http://dx.doi.org/10.1186/s12943-022-01654-1

Ejemplares similares